Salta al contenuto
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Entra
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Avanzata
  • Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
Copertina

Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Niels W. C. J. van de Donk, Philippe Moreau, Jesus F. San‐Miguel, Maria‐Victoria Mateos, Meletios A. Dimopoulos, Sonja Zweegman, Francesca Gay, Monika Engelhardt, Roberto Mina, Elena Zamagni, Michel Delforge, Meral Beksac, Andrew Spencer, Fredrik Schjesvold, Christoph Driessen, Martin Kaiser, Aurore Perrot, Ralph Wäsch, Charlotte L. B. M. Korst, Annemiek Broijl, Cyrille Touzeau, Salomon Manier, Roman Hajek, Jelena Bila, Guldane C. Seval, Michael O'Dwyer, Heinz Ludwig, Carlos Fernandez de Larrea, Rakesh Popat, Pellegrino Musto, Paula Rodriguez‐Otero, Kwee Yong, Marin Kortüm, Leo Rasche, Evangelos Terpos, Marc S. Raab, Mario Boccadoro, Pieter Sonneveld, Hermann Einsele
Natura: Artículo Open Access
Pubblicazione: Wiley 2025
Soggetti:
HemaSphere
Accesso online:
Acceder al recurso
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • Aggiungi alla lista
  • PLink permanente
  • Posseduto
  • Descrizione
  • Commenti
  • Documenti analoghi
  • MARC21

Accesso online

https://onlinelibrary.wiley.com/doi/10.1002/hem3.70260

Documenti analoghi

  • Talquetamab‐Related Dysgeusia in Multiple Myeloma Compared to BCMA ‐Targeted Bispecifics and High‐Dose Melphalan
    di: Anna Fleischer, et al.
    Pubblicazione: (2025)
  • European Myeloma Network Group Consensus Statement on the use of next‐generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
    di: Niccolò Bolli, et al.
    Pubblicazione: (2025)
  • Retreatment with talquetamab and pomalidomide in triple‐class– BCMA – GPRC5D refractory myeloma
    di: Kian J. Rahbari, et al.
    Pubblicazione: (2026)
  • Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study
    di: Meral Beksac, et al.
    Pubblicazione: (2026)
  • Reversing the sequence: Efficacy of BCMA‐directed therapy following progression on GPRC5D ‐directed therapies in relapsed multiple myeloma
    di: Laura Joiner, et al.
    Pubblicazione: (2025)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar